By utilizing the cancer genome atlas (TCGA), we have analyzed the relationship between survival probability and mRNA expression level of PXR in liver hepatocellular carcinoma (LIHC) patients, as well as in rectum adenocarcinoma (READ) patients. This evidence concerns the gene NR1I2 and cancer.